
|Articles|October 1, 2009
OVD choices mean optimised outcomes
Dr Stephen Lane believes that the large variety of available ophthalmic viscosurgical devices now allows the surgeon to tailor the surgery to meet any specific needs a patient may have.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Lumvoa gains US FDA approval for thyroid eye disease with class-first broad label
2
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
3
DEX implant shows benefit across RVO subgroups in real-world retrospective study
4

























